T cell responses to recombinant isoforms, synthetic peptides and a mutant variant of Lep d 2, a major allergen from the dust mite Lepidoglyphus destructor

被引:13
作者
Eriksson, TLJ
Gafvelin, G
Elfman, LHM
Johansson, C
Van Hage-Hamsten, M
Olsson, S
机构
[1] Karolinska Hosp & Inst, Dept Med, Allergy & Clin Immunol Unit, Stockholm, Sweden
[2] Karolinska Hosp & Inst, Dept Med, Unit Allergy Res, Stockholm, Sweden
关键词
mite; Lepidoglyphus destructor; Lep d 2; recombinant allergen; T cells; mutant allergen; isoforms; peptides; cytokines;
D O I
10.1046/j.1365-2222.2001.01242.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background The dust mite Lepidoglyphus destructor is an important cause of allergic reactions to dust, especially in farming environments. Two isoforms, recombinant (r)Lep d 2.01 and rLep d 2.02, of the major allergen Lep d 2, have previously been expressed as recombinant proteins. These isoforms differ 10.4% at the amino acid level. Furthermore, a mutant form of Lep d 2.01 (rLep d 2.6Cys) with a high-ly reduced IgE reactivity, has also been produced. Objective To investigate the T cell responses to the recombinant isoforms of Lep d 2, the Lep d 2.6Cys mutant and peptides of Lep d 2, in allergic and non-allergic individuals. Methods Peripheral blood mononuclear cells from 18 allergic and 16 non-allergic individuals were stimulated with the different antigens and the proliferative responses were measured. The cytokine production (interleukin (IL)-4, IL-5 and interferon (IFN)-gamma) were measured by ELISA. Results Higher T cell proliferation was measured to isoform 01 than to 02 in 28/34 subjects. The responses to rLep d 2.6Cys were lower than to isoform 01 in most subjects, but higher than to Lep d 2.02. Two immuno-dominant peptides, corresponding to amino acid residue 11-25 and 61-75 were identified. The atopic subjects produced significantly lower IFN-gamma in response to Lep d 2.01 as compared to the non-atopics. Conclusions There was a significant difference in T cell response between the two isoforms of rLep d 2. The hypoallergenic mutant rLep d 2.6Cys was able to evoke a T cell response with a magnitude which is between the two isoforms. Amino acid residue 11-25 and 61-75 are the most frequently recognized parts of Lep d 2 and are likely to contain the immuno-dominant T cell epitopes.
引用
收藏
页码:1881 / 1890
页数:10
相关论文
共 31 条
[1]  
Baldo B.A., 1989, Advances in the Biosciences, V74, P13
[2]   Recombinant allergens for diagnosis and therapy of allergic disease [J].
Chapman, MD ;
Smith, AM ;
Vailes, LD ;
Arruda, LK ;
Dhanaraj, V ;
Pomés, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (03) :409-418
[3]   EXPRESSION OF DERMATOPHAGOIDES-PTERONYSSINUS ALLERGEN, DER P-II, IN ESCHERICHIA-COLI AND THE BINDING-STUDIES WITH HUMAN IGE [J].
CHUA, KY ;
DILWORTH, RJ ;
THOMAS, WR .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1990, 91 (02) :124-129
[4]   SEQUENCE-ANALYSIS OF CDNA CODING FOR A MAJOR HOUSE DUST MITE ALLERGEN, DER-P-1 HOMOLOGY WITH CYSTEINE PROTEASES [J].
CHUA, KY ;
STEWART, GA ;
THOMAS, WR ;
SIMPSON, RJ ;
DILWORTH, RJ ;
PLOZZA, TM ;
TURNER, KJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (01) :175-182
[5]  
EBNER C, 1995, J IMMUNOL, V154, P1932
[6]   IgE binding capacity of synthetic and recombinant peptides of the major storage mite (Lepidoglyphus destructor) allergen, Lep d 2 [J].
Elfman, LHM ;
Whitley, P ;
Schmidt, M ;
van Hage-Hamsten, M .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1998, 117 (03) :167-173
[7]   Cloning and characterisation of a group II allergen from the dust mite Tyrophagus putrescentiae [J].
Eriksson, TLJ ;
Johansson, E ;
Whitley, P ;
Schmidt, M ;
Elsayed, S ;
Van Hage-Hamsten, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 251 (1-2) :443-447
[8]   Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: Potential use of hypoallergenic isoforms for immunotherapy [J].
Ferreira, F ;
Hirtenlehner, K ;
Jilek, A ;
GodnikCvar, J ;
Breiteneder, H ;
Grimm, R ;
HoffmannSommergruber, K ;
Scheiner, O ;
Kraft, D ;
Breitenbach, M ;
Rheinberger, HJ ;
Ebner, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :599-609
[9]  
GEISSELSODER J, 1987, BIOTECHNIQUES, V5, P786
[10]  
Hales BJ, 1997, CLIN EXP ALLERGY, V27, P868, DOI 10.1111/j.1365-2222.1997.tb01226.x